Transaction brings Qunol®, a trusted, profitable double-digit growth and market-leading brand in health & wellness to Sanofi’s CHC U.S. por...
InSilicoTrials, a leading provider of artificial intelligence (AI) and simulation tools for drug and medical device development, has embarked on a ...
Hyro, the leader in conversational artificial intelligence (AI) for healthcare, today announced a partnership with Gozio Health, an industry-leading, custo...
"The FDA continues to seek new ways to advance science to address the public health challenges that families and communities across the country face," said...
Through TrialHub's data intelligence gathering platform, EmVenio can easily identify optimal markets to attract clinical trial participants who are needed ...
New service leverages speech recognition and generative AI to automatically create preliminary clinical documentation from patient-clinician conversations ...
National Dental Centre Singapore’s research arm, the National Dental Research Institute Singapore (NDRIS) has established an international collaborat...
Analyses Show Oral Bridging Maintains Virologic Suppression When Subcutaneous Lenacapavir Doses are Missed – Gilead Sciences, Inc. (Na...
IntelGenx Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") announced the execution of a Research Grant Agreement with Karolinska Unive...
India based Lupin Digital Health and the American College of Cardiology (ACC) have announced a first-of-its-kind collaboration to deliver in-home cardiovas...
"We are excited for achieving this important milestone, which also marked the first step to what we hope will ultimately allow us to bring an innovative ca...
Pfizer confirms all its colleagues are safe following a tornado that damaged predominantly the warehouse portion of its manufacturing facility in Rocky M...
Optogenetic platform will be combined with AI at Integrated Biosciences to identify candidate anti-aging drugs Scientists demonstrate that cells make an i...
It is a multi-center, open-label clinical study to evaluate the efficacy and safety of fruquintinib in combination with sintilimab. Entry criteria include ...
© 2025 Biopharma Boardroom. All Rights Reserved.
